David Citadel Hotel & Conference Center

Jerusalem, Israel
September 8-11, 2024

 

Attend the world’s most comprehensive hematology/oncology event on Waldenstrom’s macroglobulinemia; the 12^th International Workshop on Waldenstrom’s macroglobulinemia (IWWM-12).

The 12th International Workshop for Waldenstrom's Macroglobulinemia is being held September 8^th to September 11^th, 2024 in Jerusalem, Israel. The venue chosen for this meeting is one of Jerusalem’s premier hotels, The David Citadel Jerusalem , Israel (thejerusalemhotels.com) located in the old part in the city of Jerusalem . The hotel nestles in one of the city’s most historic areas linking the city’s most enriching museums; Israel museum, Yad Vashem, the monumental Jaffa Gate,  vibrant parks and gardens, and epicurean eateries.

Onsite registration and check-in will be from 14:00 (2:00pm) to 18:00 (6:00pm) on Sunday, September 8^th, conference sessions starting on Monday, the 9^th, at 8:00am.

The Workshop’s mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic system, by promoting targeted research, clinical care methods, education, training, and advocacy for Waldenstrom’s macroglobulinemia.

IWWM-12 will continue to support future research by including a Junior Investigator Poster presentation event with short oral presentations. Abstract submissions for poster presentations will begin in May 2024.

Opening Ceremonies will take place on Monday, September 9^th with dinner in the Grand ballroom followed by presentations of the R. Kyle Award and Young Investigator Awards at the Tower of David Jerusalem museum. 

The Closing Ceremonies will take place on Wednesday, September 11^th at the Israel art museum. The ceremony will feature the presentations of the Jan Gosta Waldenstrom Awards, the Peter S. Bing Humanitarian Awards, and special guest presentations. 

We expect this international Workshop to be as comprehensive as IWWM-11, which included 20 sessions with over 90 technical presentations.  Since the IWWM began in 2000, the number of participating international investigators has steadily grown to over 30 countries, and over 8,600 publications including those created and developed from the IWWM Workshops. These publications have been published in the New England Journal of Medicine, Blood, Clinical Lymphoma Myeloma, Haematologica, Journal of Clinical Oncology, Leukemia, Nature, Lancet,  and other top publications.  
The IWWM-12 workshops will continue the mission to enrich each attendee’s understanding and help foster research discoveries and lifetime collaborations leading to more effective treatments and ultimately find a cure for Waldenstrom's macroglobulinemia.

We look forward to welcoming you to the Workshop!

 

Dana-Farber Cancer Institute
Harvard Medical School
Boston, MA, USA

Hadassah Medical Organization
The Hebrew University of Jerusalem

Dana-Farber Cancer Institute
Harvard Medical School
Boston, MA, USA